Ridgetech, Inc. (NASDAQ: RDGT) Stock Competitors & Peer Comparison
See RDGT's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RDGT and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RDGT | $0.81 | -1.41% | 729.3K | -0.01 | -$54.23 | N/A |
| MCK | $853.71 | -1.79% | 99.9B | 20.91 | $40.82 | +0.38% |
| COR | $317.10 | +0.31% | 61.7B | 18.48 | $17.15 | +0.75% |
| CAH | $234.85 | -0.06% | 55B | 22.52 | $10.43 | +0.86% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $89.29 | +0.07% | 10.2B | 16.82 | $5.31 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +2.49% |
| PBH | $51.68 | +3.28% | 2.4B | 11.44 | $4.42 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
| ACH | $1.32 | +17.33% | 101.1M | 1.94 | $0.68 | N/A |
Stock Comparison
McKesson Corporation (NYSE: MCK)
RDGT vs MCK Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, MCK has a market cap of 99.9B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while MCK trades at $853.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas MCK's P/E ratio is 20.91. In terms of profitability, RDGT's ROE is -0.04%, compared to MCK's ROE of -1.94%. Regarding short-term risk, RDGT is more volatile compared to MCK. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check MCK's competition here
Cencora, Inc. (NYSE: COR)
RDGT vs COR Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, COR has a market cap of 61.7B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while COR trades at $317.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas COR's P/E ratio is 18.48. In terms of profitability, RDGT's ROE is -0.04%, compared to COR's ROE of +1.06%. Regarding short-term risk, RDGT is more volatile compared to COR. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check COR's competition here
Cardinal Health, Inc. (NYSE: CAH)
RDGT vs CAH Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, CAH has a market cap of 55B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while CAH trades at $234.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas CAH's P/E ratio is 22.52. In terms of profitability, RDGT's ROE is -0.04%, compared to CAH's ROE of -0.60%. Regarding short-term risk, RDGT is more volatile compared to CAH. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check CAH's competition here
AmerisourceBergen Corporation (NYSE: ABC)
RDGT vs ABC Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas ABC's P/E ratio is 21.92. In terms of profitability, RDGT's ROE is -0.04%, compared to ABC's ROE of +1.06%. Regarding short-term risk, RDGT is more volatile compared to ABC. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check ABC's competition here
Henry Schein, Inc. (NASDAQ: HSIC)
RDGT vs HSIC Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, HSIC has a market cap of 10.2B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while HSIC trades at $89.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas HSIC's P/E ratio is 16.82. In terms of profitability, RDGT's ROE is -0.04%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, RDGT is more volatile compared to HSIC. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check HSIC's competition here
Patterson Companies, Inc. (NASDAQ: PDCO)
RDGT vs PDCO Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas PDCO's P/E ratio is 20.48. In terms of profitability, RDGT's ROE is -0.04%, compared to PDCO's ROE of +0.18%. Regarding short-term risk, RDGT is more volatile compared to PDCO. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check PDCO's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
RDGT vs PBH Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while PBH trades at $51.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas PBH's P/E ratio is 11.44. In terms of profitability, RDGT's ROE is -0.04%, compared to PBH's ROE of +0.09%. Regarding short-term risk, RDGT is more volatile compared to PBH. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check PBH's competition here
Owens & Minor, Inc. (NYSE: OMI)
RDGT vs OMI Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas OMI's P/E ratio is -0.47. In terms of profitability, RDGT's ROE is -0.04%, compared to OMI's ROE of +0.63%. Regarding short-term risk, RDGT is less volatile compared to OMI. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check OMI's competition here
Accendra Health, Inc. (NYSE: ACH)
RDGT vs ACH Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, ACH has a market cap of 101.1M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while ACH trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas ACH's P/E ratio is 1.94. In terms of profitability, RDGT's ROE is -0.04%, compared to ACH's ROE of +0.63%. Regarding short-term risk, RDGT is less volatile compared to ACH. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check ACH's competition here
Akso Health Group (NASDAQ: HX)
RDGT vs HX Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas HX's P/E ratio is -1.84. In terms of profitability, RDGT's ROE is -0.04%, compared to HX's ROE of -1.07%. Regarding short-term risk, RDGT is less volatile compared to HX. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check HX's competition here
111, Inc. (NASDAQ: YI)
RDGT vs YI Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, YI has a market cap of 31.9M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while YI trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas YI's P/E ratio is -2.61. In terms of profitability, RDGT's ROE is -0.04%, compared to YI's ROE of +0.14%. Regarding short-term risk, RDGT is more volatile compared to YI. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check YI's competition here
Wellgistics Health, Inc. (NASDAQ: WGRX)
RDGT vs WGRX Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, WGRX has a market cap of 8.7M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while WGRX trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas WGRX's P/E ratio is -0.33. In terms of profitability, RDGT's ROE is -0.04%, compared to WGRX's ROE of +8.78%. Regarding short-term risk, RDGT is less volatile compared to WGRX. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check WGRX's competition here
Zynex, Inc. (NASDAQ: ZYXI)
RDGT vs ZYXI Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, ZYXI has a market cap of 3.8M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while ZYXI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas ZYXI's P/E ratio is -0.05. In terms of profitability, RDGT's ROE is -0.04%, compared to ZYXI's ROE of +11.38%. Regarding short-term risk, RDGT is more volatile compared to ZYXI. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check ZYXI's competition here
DataMEDS AI, Inc. (NASDAQ: MEDS)
RDGT vs MEDS Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, MEDS has a market cap of 3.8M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while MEDS trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas MEDS's P/E ratio is N/A. In terms of profitability, RDGT's ROE is -0.04%, compared to MEDS's ROE of +8.78%. Regarding short-term risk, RDGT is less volatile compared to MEDS. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check MEDS's competition here
ZeroStack Corp. (NASDAQ: ZSTK)
RDGT vs ZSTK Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, ZSTK has a market cap of 2.5M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while ZSTK trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas ZSTK's P/E ratio is -0.05. In terms of profitability, RDGT's ROE is -0.04%, compared to ZSTK's ROE of -3.82%. Regarding short-term risk, RDGT is less volatile compared to ZSTK. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check ZSTK's competition here
Synergy CHC Corp. (NASDAQ: SNYR)
RDGT vs SNYR Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, SNYR has a market cap of 1.1M. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while SNYR trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas SNYR's P/E ratio is -0.08. In terms of profitability, RDGT's ROE is -0.04%, compared to SNYR's ROE of +0.91%. Regarding short-term risk, RDGT is less volatile compared to SNYR. This indicates lower risk in terms of short-term price fluctuations for RDGT.Check SNYR's competition here
Covetrus, Inc. (NASDAQ: CVET)
RDGT vs CVET Comparison August 2026
Ridgetech, Inc. (NASDAQ: RDGT) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 729.3K. In comparison, CVET has a market cap of 0. Regarding current trading prices, RDGT is priced at $0.81 on the NASDAQ, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.01, whereas CVET's P/E ratio is -69.97. In terms of profitability, RDGT's ROE is -0.04%, compared to CVET's ROE of -0.06%. Regarding short-term risk, RDGT is more volatile compared to CVET. This indicates higher risk in terms of short-term price fluctuations for RDGT.Check CVET's competition here